F000083319: ALPRAZOLAM TABLETS.
The ALPRAZOLAM TABLETS is a the manufacturer industrial component. Key specifications include administration: ORAL, primary_container_type: BOTTLE, protective_storage_feature: EXPIRATION DATED AND SECURITY STORAGE, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, primary_container_content_quantity: 500.000 TABLETS, controlled_substance_classification: SCHEDULE IV. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-196-9501, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| administration | ORAL |
| primary_container_type | BOTTLE |
| protective_storage_feature | EXPIRATION DATED AND SECURITY STORAGE |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| primary_container_content_quantity | 500.000 TABLETS |
| controlled_substance_classification | SCHEDULE IV |
| active_medicament_medicinal_strength | 0.500 MILLIGRAMS ALPRAZOLAM ACTIVE INGREDIENT |
| part_name_assigned_by_controlling_agency | XANAX (ALPRAZOLAM) 0.5 MG TABLET, 500S |
| NSN | 6505-01-196-9501 |
| CONTROLLED SUBSTANCE CLASSIFICATION | SCHEDULE IV |
| ADMINISTRATION | ORAL |
| PRIMARY CONTAINER CONTENT QUANTITY | 500.000 TABLETS |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PRIMARY CONTAINER TYPE | BOTTLE |
| SPECIAL FEATURES | ALPRAZOLAM TABLETS,USP; SCHEDULE IV CONTROLLED SUBSTANCE; EACH TABLET FOR ORAL ADMINISTRATION CONTAINS 0.5 MILLIGRAMS OF ALPRAZOLAM AS THE ACTIVE INGREDIENT; STRENGTH: 0.5 MILLIGRAMS; STORE AT 20-25 DEG C (68-77 DEG F);(SEE USP CONTROLLED ROOM TEMPERATURE) DEGC |
| PROTECTIVE STORAGE FEATURE | EXPIRATION DATED AND SECURITY STORAGE |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | XANAX (ALPRAZOLAM) 0.5 MG TABLET, 500S |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 0.500 MILLIGRAMS ALPRAZOLAM ACTIVE INGREDIENT |